Results 161 to 170 of about 124,712 (211)

Unmasking pulmonary actinomycosis: A diagnostic challenge in a young immunocompetent male. [PDF]

IDCases
Othman R, Shosha D, Alansari L, Aljohani F, Alansari N, Alghamdi A, Alsharhan Y, Alsaeed M, Alibrahim A, Alshehri S, Ahmad S, Alsaeed M.   +11 more
europepmc   +1 more source

Genetic variation at transcription factor binding sites largely explains phenotypic heritability in maize. [PDF]

Nat Genet
Engelhorn J, Snodgrass SJ, Kok A, Seetharam AS, Schneider M, Kiwit T, Singh A, Banf M, Doan DTH, Khaipho-Burch M, Runcie DE, Sánchez-Camargo VA, Bader R, Vladimir Torres-Rodriguez J, Sun G, Stam M, Fiorani F, Beier S, Schnable JC, Bass HW, Hufford MB, Stich B, Frommer WB, Ross-Ibarra J, Hartwig T.   +24 more
europepmc   +1 more source

Aerospace Corporation and Aerospace Professional Staff Association (APSA) (2004) [PDF]

, 2004

core   +1 more source

Why rat oral cavity tumors should not be the basis of quantitative cancer risk assessment for oral exposure to hexavalent chromium. [PDF]

Toxicol Sci
Proctor D, Jiang X, Reichert H, Thompson C.   +3 more
europepmc   +1 more source

Impact of the COVID-19 pandemic on medical office assistants (MOAs) working in primary care: a qualitative study. [PDF]

BJGP Open
Johnson JK, Ryan BL, Terry AL, Brown JB.
europepmc   +1 more source

Chiral supramolecular assembly to enhance the magneto-optical rotation of organic materials. [PDF]

Nat Commun
Delage-Laurin L, Reger D, Suleymanov AA, Nelson Z, Minion L, Kooi SE, Brandt JR, Siligardi G, Cameron RP, Wade J, Swager TM, Fuchter MJ.   +11 more
europepmc   +1 more source

Effects of behavior change techniques in interventions promoting condom use among youth in the Global North. [PDF]

PLoS One
de Vries A, Heijne JCM, de Wit JBF, den Daas C.   +3 more
europepmc   +1 more source

Untargeted metabolomics for triaging of cytochrome b inhibitors during Chagas' disease drug discovery. [PDF]

PLoS Negl Trop Dis
MacLeod AK, Tulloch LB, Tinti M, Edwards D, Wyllie S, Read KD.   +5 more
europepmc   +1 more source

NX210c Demonstrates Therapeutic Potential to Restore Blood-Brain Barrier in a QSP Model of Relapsing-Remitting Multiple Sclerosis. [PDF]

Int J Mol Sci
Russo G, Sips F, Catozzi S, Bambury P, Janus A, Torchia M, Di Salvatore V, Emili L, Röshammar D, Pappalardo F, Godfrin Y.   +10 more
europepmc   +1 more source

Synergistic effects of vedolizumab and JAK 1,2,3 inhibitors in Crohn's disease: insights from a systems biology and artificial intelligence-based approach. [PDF]

Front Immunol
Marín-Jiménez I, Sierra-Ausín M, Letosa-Abián T, Aparicio J, Montoto-Otero C, Sánchez-Ramón S.   +5 more
europepmc   +1 more source